Estimates Revisions Harbin Pharmaceutical Group Co., Ltd.
Stocks
600664
CNE0000009T3
Pharmaceuticals
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 5.890 CNY | +5.94% |
|
+9.07% | +70.72% |
| 07-30 | Harbin Pharmaceutical Gets Marketing Approval for Potassium Sulfate API | MT |
| 04-22 | Harbin Pharmaceutical Group Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2026 | CI |
Turnover - Evolution of Analysts' Estimates
Earnings Per Share (EPS) - Evolution of Analysts' Estimates
EBIT - Evolution of Analysts' Estimates
| 1m. Revenue rev. | 1y. Revenue rev. | 1y. EPS revision | ||
|---|---|---|---|---|
 | ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| Average | ||||
| Weighted average by Cap. |
Turnover
Earnings Per Share (EPS)
EBIT
- Stock Market
- Stocks
- 600664 Stock
- Consensus Harbin Pharmaceutical Group Co., Ltd.
- Estimates Revisions
Select your edition
All financial news and data tailored to specific country editions
